PGH2 is degraded to 12S-HHT and MDA by TBXAS1

Stable Identifier
R-HSA-2161613
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Synonyms
prostaglandin H2 => (12S)-hydroxy-(5Z,8E,10E)-heptadecatrienoate + malonaldehyde
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Thromboxane synthase (TBXAS1) aka CYP5A1 facilitates rearrangement of the PGH2 endoperoxide bridge by a complementary mechanism to prostacyclin synthase, interacting with the C-9 oxygen to promote endoperoxide bond cleavage. The C-11 oxygen radical initiates intramolecular rearrangement, resulting in either the formation of thromboxane A2 (TXA2) or 12-hydroxyheptadecatrienoic acid (12S-HHT) and malonaldehyde (MDA) (Wang et al. 2001).
Literature References
PubMed ID Title Journal Year
11297515 Substrate binding is the rate-limiting step in thromboxane synthase catalysis

Tsai, AL, Wang, LH, Hsu, PY

J Biol Chem 2001
Participants
Participates
Catalyst Activity

12-hydroxyheptadecatrienoic acid synthase activity of TBXAS1 [endoplasmic reticulum membrane]

Orthologous Events
Cross References
RHEA
Rhea
Authored
Reviewed
Created
Cite Us!